MT MPJE flashcards
MT MPJE · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Montana Board of Pharmacy
- State agency that licenses pharmacists, technicians, and pharmacy outlets and enforces the Montana Pharmacy Practice Act through rules, inspections, and disciplinary action.
- Pharmacist-in-charge duties
- The PIC is responsible for the pharmacy's compliance with drug laws, recordkeeping, security, and supervision of personnel; changes in PIC must be reported to the Board as required by rule.
- Technician registration
- Montana requires pharmacy technicians to register with the Board; certified technicians may perform expanded duties defined in rule, but pharmacists retain final verification responsibility.
- CQI program requirement
- Montana pharmacies must maintain a documented continuous quality improvement program that reviews dispensing errors and quality-related events and retains records for Board review.
- Montana PDMP reporting
- Dispensers report controlled substance prescriptions to the Montana Prescription Drug Registry on the schedule set by rule; pharmacists may query the registry when clinically appropriate.
- Immunization by pharmacists
- Montana pharmacists may administer vaccines under a protocol or prescription, with required training, CPR certification, documentation, and reporting to the state immunization information system.
- Collaborative drug therapy
- Montana permits pharmacists to participate in collaborative practice under a written protocol with a prescriber, allowing defined drug therapy management and monitoring activities.
- Generic substitution
- A pharmacist may substitute a therapeutically equivalent generic product unless the prescriber prohibits substitution; the patient must be informed and records maintained per rule.
- Pharmacy license per location
- Each pharmacy location must hold a current Board license; relocation, ownership change, or closure triggers notification or new licensure requirements under Montana rules.
- Patient counseling duty
- Pharmacists must offer counseling on new and changed prescriptions, covering directions, precautions, and interactions, unless the patient declines or an exception applies.
- Prescription transfer rules
- Prescriptions may be transferred between pharmacies as permitted by law; controlled substance transfers are limited, and Schedule II prescriptions generally cannot be refilled after transfer.
- Record retention
- Montana pharmacies must retain prescription and dispensing records for the period set by Board rule and make them available for inspection on request.
- Unprofessional conduct
- Grounds for discipline include dispensing without a valid prescription, impaired practice, falsifying records, and violating Board rules or drug laws.
- Schedule II refills
- Schedule II prescriptions may not be refilled; a new prescription is required, and emergency oral orders must be followed by a written prescription within 7 days.
- Schedule III-V refills
- Prescriptions for Schedule III through V drugs may be refilled up to 5 times within 6 months of the issue date unless the prescriber directs otherwise.
- DEA Form 106
- Report used to document theft or significant loss of controlled substances; it must be submitted to the DEA field office within one business day of discovery.
- Biennial inventory
- DEA requires a complete inventory of controlled substances every two years, with Schedule II counted separately and records retained for at least two years.
- EPCS requirements
- Electronic controlled substance prescriptions require DEA-compliant software, identity proofing, and two-factor authentication; pharmacists must verify compliance before dispensing.
- DEA registration renewal
- DEA registrations are valid for three years and must be renewed before expiration; dispensing without a current registration violates federal law.
- Partial fill Schedule II
- A Schedule II prescription may be partially filled when the pharmacist cannot supply the full quantity; the remainder must be dispensed within 30 days.
- HIPAA minimum necessary
- Covered entities must limit protected health information disclosures to the minimum necessary for the purpose, except for treatment disclosures and certain required reporting.
- DSCSA verification
- The Drug Supply Chain Security Act requires trading partners to verify suspect or illegitimate product and maintain transaction information, statements, and histories.
- Prescription validity
- A valid prescription must be issued for a legitimate medical purpose by a prescriber acting in the usual course of practice; pharmacists must resolve red flags before dispensing.
- Corresponding responsibility
- Pharmacists share responsibility with prescribers to ensure controlled substance prescriptions are valid and issued for a legitimate medical purpose.
- Controlled substance records
- Records of receipt, dispensing, and disposal of controlled substances must be maintained for two years and kept separate or readily retrievable for DEA inspection.
- Schedule I status
- Schedule I substances have high abuse potential and no accepted medical use; they cannot be prescribed or dispensed by pharmacists under federal law.
- Emergency oral Schedule II
- In an emergency, a prescriber may phone in a Schedule II prescription; the pharmacist may dispense it if a written prescription arrives within 7 days.
- DEA Form 222
- Form used to order Schedule I and II controlled substances; it must be completed accurately, and records of distributions must be retained for inspection.
- FDA labeling requirements
- Prescription drugs must bear FDA-approved labeling with adequate directions for use; pharmacists must dispense with required labeling and auxiliary information.
- Poison Prevention Packaging
- Federal law requires child-resistant packaging for most prescription drugs unless the patient requests otherwise or the prescriber directs noncomplying packaging.
- Refill authorization
- A pharmacist may dispense refills only as authorized by the prescriber; unauthorized refills or extensions violate federal and state law.
- Reporting theft or loss
- Pharmacies must notify DEA in writing of theft or significant loss within one business day and complete a DEA Form 106 describing the circumstances.